Trial · NCT03011450
Outcomes114
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 114
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percent Change in Fasting TG From Baseline to Week 12 | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Remnant Cholesterol | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in HDL-C | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Apo A1 | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Non-HDL-C | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Total Cholesterol | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in LDL-C | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in FFAs | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Apo A2 | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Apo B | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Apo B48 | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Apo B100 | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Apo C2 | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Apo C3 | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Apo E | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Change From Baseline to Week 12 in FGF21 | 12 Weeks | pg/mL | MEDIAN | |
| SECONDARY | Change From Baseline to Week 12 in hsCRP | 12 Weeks | mg/L | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Ion Mobility (VLDL Cholesterol-Large) | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Ion Mobility (VLDL Cholesterol-Intermediate) | 12 Weeks | Percent change | MEDIAN | |
| SECONDARY | Percent Change From Baseline to Week 12 in Ion Mobility (VLDL Cholesterol-Small) | 12 Weeks | Percent change | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03011450/outcomes